BIOMAT Database Logo BIOMAT Database Logo

Changes in plasma HDL-cholesterol in women using oral contraceptives in Kenya. 1987

F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati

UI MeSH Term Description Entries
D007630 Kenya A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi. Republic of Kenya
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D009644 Norgestrel A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis. 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-,DL-Norgestrel,Neogest,Ovrette,Postinor,Wy-3707,DL Norgestrel,Wy 3707,Wy3707
D003278 Contraceptives, Oral, Hormonal Oral contraceptives which owe their effectiveness to hormonal preparations. Hormonal Oral Contraceptive,Hormonal Oral Contraceptive Agent,Contraceptive Agents, Estrogen,Contraceptive Agents, Oral, Hormonal,Hormonal Oral Contraceptive Agents,Oral Contraceptive Agents, Hormonal,Oral Contraceptives, Hormonal,Contraceptive, Hormonal Oral,Contraceptives, Hormonal Oral,Estrogen Contraceptive Agents,Hormonal Oral Contraceptives,Oral Contraceptive, Hormonal
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D019304 Ethinyl Estradiol-Norgestrel Combination ETHINYL ESTRADIOL and NORGESTREL given in fixed proportions. Norgestrel-Ethinyl Estradiol Combination,Adepal,Anteovin,Eugynon,Gravistat,Leios,Minisiston,Nordette,Ovidon,Ovral,Pearl Oral Contraceptive,Rigevidon,Sequostat,Stediril,Trigynon,Trinordiol,Triphasil,Triquilar,Trisiston,Trisistone R,Trisistone-R,Contraceptive, Pearl Oral,Estradiol Combination, Norgestrel-Ethinyl,Estradiol-Norgestrel Combination, Ethinyl,Ethinyl Estradiol Norgestrel Combination,Norgestrel Ethinyl Estradiol Combination,Oral Contraceptive, Pearl,TrisistoneR

Related Publications

F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
Serum HDL-cholesterol in women using low dose oral contraceptives.
July 2007, Mymensingh medical journal : MMJ,
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
[Oral contraceptives and HDL cholesterol].
January 1979, Lakartidningen,
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
[Antithrombin 3 changes in women using oral contraceptives].
January 1974, Pathologie-biologie,
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
Plasma lipids in women using progestogen-only oral contraceptives.
June 1983, British journal of obstetrics and gynaecology,
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
Plasma ascorbate and HDL-cholesterol in women.
January 1982, Human nutrition. Clinical nutrition,
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
Combined-type oral contraceptives and plasma triglyceride and cholesterol levels of young women.
July 1977, Nutrition reports international,
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
Cryofibrinogenaemia in women using oral contraceptives.
January 1970, Lancet (London, England),
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
Cryofibrinogenaemia in women using oral contraceptives.
May 1970, Lancet (London, England),
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
Cryofibrinogenaemia in women using oral contraceptives.
April 1970, Lancet (London, England),
F W Maina, and C B Sekadde-Kigondu, and P J Ojwang, and J K Mati
Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol.
September 1979, Circulation,
Copied contents to your clipboard!